Version history

11 versions on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/27/2026, 2:59:17 PM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "world_model_rank": 0,
      "kg_impact_score": 0,
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html",
      "reproducibility_class": "observational"
    }
  2. v10
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  3. v9
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  4. v8
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  5. v7
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  6. v6
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  7. v5
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  8. v4
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  9. v3
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  10. v2
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }
  11. v1
    4/1/2026, 12:00:00 AM
    Content snapshot
    {
      "question": "What are the mechanisms underlying blood-brain barrier transport mechanisms for antibody therapeutics?",
      "domain": "neurodegeneration",
      "status": "archived",
      "triggered_by": "autonomous_agent",
      "completed_at": "2026-04-01T00:00:00-07:00",
      "report_url": "/analyses/sda-2026-04-01-gap-008.html"
    }